Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick P J Phillips

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2017
Setting Tuberculosis Regimen Development on a Firm FoundationPatrick P J Phillips
American Journal of Respiratory and Critical Care Medicine|September 27, 2022
To Err Is Human, to Forgive Is PharmacodynamicPatrick P J Phillips, Jason E Stout
The New England Journal of Medicine|September 12, 2019
A Shorter Regimen for Rifampin-Resistant Tuberculosis. ReplyAndrew J Nunn, Patrick P J Phillips
Future Medicinal Chemistry|March 24, 2011
Challenges of Phase III study design for trials of new drug regimens for the treatment of TBPatrick P J Phillips, Andrew J Nunn
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2013
An analysis with serious flawsAndrew J Nunn, Patrick P J Phillips
Current Opinion in Pulmonary Medicine|March 27, 2013
Treatment of pulmonary tuberculosisAndrew Nunn, Patrick P J Phillips, Ibrahim Abubakar
Plos One|May 14, 2013
An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapsePatrick P J Phillips, Katherine Fielding, Andrew J Nunn
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 14, 2015
Reducing relapse in tuberculosis treatmentAndrew J Nunn, Patrick P J Phillips, Ibrahim Abubakar
Tuberculosis (Edinburgh, Scotland)|October 10, 2008
Design issues in pivotal drug trials for drug sensitive tuberculosis (TB)Andrew J Nunn, Patrick P J Phillips, Stephen H Gillespie
Trials|March 12, 2024
Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trialIsabelle R Weir, Suzanne M Dufault, Patrick P J Phillips
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2017
Setting Tuberculosis Regimen Development on a Firm FoundationPatrick P J Phillips
American Journal of Respiratory and Critical Care Medicine|September 27, 2022
To Err Is Human, to Forgive Is PharmacodynamicPatrick P J Phillips, Jason E Stout
The New England Journal of Medicine|September 12, 2019
A Shorter Regimen for Rifampin-Resistant Tuberculosis. ReplyAndrew J Nunn, Patrick P J Phillips
Future Medicinal Chemistry|March 24, 2011
Challenges of Phase III study design for trials of new drug regimens for the treatment of TBPatrick P J Phillips, Andrew J Nunn
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2013
An analysis with serious flawsAndrew J Nunn, Patrick P J Phillips
Current Opinion in Pulmonary Medicine|March 27, 2013
Treatment of pulmonary tuberculosisAndrew Nunn, Patrick P J Phillips, Ibrahim Abubakar
Plos One|May 14, 2013
An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapsePatrick P J Phillips, Katherine Fielding, Andrew J Nunn
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 14, 2015
Reducing relapse in tuberculosis treatmentAndrew J Nunn, Patrick P J Phillips, Ibrahim Abubakar
Tuberculosis (Edinburgh, Scotland)|October 10, 2008
Design issues in pivotal drug trials for drug sensitive tuberculosis (TB)Andrew J Nunn, Patrick P J Phillips, Stephen H Gillespie
Trials|March 12, 2024
Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trialIsabelle R Weir, Suzanne M Dufault, Patrick P J Phillips
Pageof 12